GAK is thought to influence PD by affecting the endocytic pathway within glia and potentially modulating the aggregation and clearance of SNCA/alpha-synuclein, a protein that forms toxic aggregates in the brains of individuals with PD. The gene discussed is SNCA; the disease is Parkinson disease.